deltatrials
Completed NA NCT00214825

Aldosterone and Vascular Disease in Diabetes Mellitus

Sponsor: Brigham and Women's Hospital

Conditions Albuminuria Diabetes Mellitus Endothelial Dysfunction
Interventions Hydrochlorothiazide eplerenone
Updated 6 times since 2017 Last updated: Dec 28, 2007 Started: Aug 31, 2003 Primary completion: Mar 31, 2006 Completion: Mar 31, 2006

A NA clinical study on Albuminuria and Diabetes Mellitus, this trial is completed. The trial is conducted by Brigham and Women's Hospital and has accumulated 6 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Feb 2017 — Jun 2018 [monthly]

    Completed NA

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed NA

    First recorded

Aug 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Brigham and Women's Hospital
  • National Institutes of Health (NIH)
Data source: Brigham and Women's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Boston, United States